Target & Activity
| Target | Activity | Value |
|---|---|---|
| IDO | Ki | 19 μM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | IC50 | > 100 μM | Anticancer activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay | [PMID: 31954880] |
| HeLa | IC50 | > 100 μM | Anticancer activity against human HeLa cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay | [PMID: 31954880] |
| HeLa | EC50 | 110 μM | Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells using L-tryptophan as substrate after 24 hrs | [PMID: 28526475] |
| HUVEC | IC50 | > 100 μM | Cytotoxicity against HUVEC cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay | [PMID: 31954880] |
| PC-3 | IC50 | > 100 μM | Anticancer activity against human PC3 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay | [PMID: 31954880] |
| U-87MG ATCC | IC50 | 148.9 μM | Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry | [PMID: 27475108] |